What's New on the FDA Drugs Site
April 21, 2017
- Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (updated)
- Product-Specific Guidances for Generic Drug Development (updated)
- CDER SBIA Chronicles and Audio Podcast: The Complexities of Compounding
- Disposal of unused medicines: How to find a drug collection site near you
- Drug Approval Package: Zejula (niraparib)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Calcium Chloride Injection, USP (Updated - Currently in Shortage)
- Cefepime Injection (Updated - Currently in Shortage)
- Disopyramide Phosphate (Norpace) Capsules (Updated - Currently in Shortage)
- Estradiol Valerate Injection, USP (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated - Currently in Shortage)
- Penicillin G Benzathine and Penicillin G Procaine (Bicillin C-R) Injection (Updated - Currently in Shortage)
- Penicillin G Procaine Injection (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (New - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Rocuronium Bromide Injection (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
- Learn about CDER Small Business and Industry Assistance (video)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario